Plaquenil pregnancy drug class

Discussion in 'Aralen' started by vistarus, 19-Mar-2020.

  1. ivanm Guest

    Plaquenil pregnancy drug class


    Malaria: Treatment of uncomplicated malaria caused by susceptible strains of Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium falciparum; prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. Limitations of use: Hydroxychloroquine is not effective against chloroquine- or hydroxychloroquine-resistant malaria strains of Plasmodium species; not recommended for treatment of complicated malaria, malaria prophylaxis in regions with chloroquine resistance, or treatment when the Plasmodium species has not been identified; hydroxychloroquine does not prevent relapses of P. ovale infections because it is not effective against the hypnozoite forms of these parasites.

    Hydroxychloroquine clinical trial cancer Plaquenil and heartburn Hydroxychloroquine sulfate and psoriasis

    Safety of hydroxychloroquine in pregnant patients with connective tissue diseases a study of one hundred thirty-three cases compared with a control group. Costedoat-Chalumeau N1, Amoura Z, Duhaut P, Huong DL, Sebbough D, Wechsler B, Vauthier D, Denjoy I, Lupoglazoff JM, Piette JC. Hydroxychloroquine is in a class of drugs called antimalarials. It is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments. The drug label advises that hydroxychloroquine should not be prescribed to individuals with known hypersensitivity to 4-Aminoquinoline compounds. There are a range of other contraindications 13 14 and caution is required if patients have certain heart conditions, diabetes, psoriasis etc.

    Data from case reports and retrospective and open-label studies support the use of hydroxychloroquine in the treatment of cutaneous manifestations of dermatomyositis . Rheumatoid arthritis: Treatment of acute and chronic rheumatoid arthritis in adults.

    Plaquenil pregnancy drug class

    Plaquenil Oral Uses, Side Effects, Interactions, Pictures., Hydroxychloroquine MedlinePlus Drug Information

  2. Reticulocytes chloroquine treatment p62
  3. Chloroquine over the counter usa
  4. Among many non-biologic immunosuppressive drugs, hydroxychloroquine and cyclosporine are considered relatively ‘safe’ to use in pregnancy. Hydroxychloroquine can cross the placenta, but appears to have no effects on congenital defects, fetal death, or prematurity.7-9 Safety data on use of cyclosporine in pregnancy from transplant patients.

    • Safety of Immunosuppressive Drugs in Pregnant Women with..
    • Hydroxychloroquine - Wikipedia.
    • Hydroxychloroquine Oral Uses, Side Effects, Interactions..

    The full risks of using Plaquenil hydroxychloroquine during pregnancy are not known at this time. This eMedTV segment includes more information on Plaquenil and pregnancy, and explains whether the drug is likely to affect a fetus. US FDA pregnancy category Not Assigned The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of. PLAQUENIL prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

     
  5. Donatello Well-Known Member

    400-600 mg (310-465 mg base) PO daily for 4-12 weeks; maintenance: 200-400 mg (155-310 mg base) PO daily With prolonged therapy, obtain CBCs periodically 400 mg (310 mg base) PO once or twice daily; maintenance: 200-400 mg (155-310 mg base) PO daily With prolonged therapy, obtain CBCs periodically 100-200 mg (77.5-155 mg base) PO 2-3 times/wk Take with food or milk Nausea, vomiting Headache Dizziness Irritability Muscle weakness Aplastic anemia Leukopenia Thrombocytopenia Corneal changes or deposits (visual disturbances, blurred vision, photophobia; reversible on discontinuance) Retinal damage with long-term use Bleaching of hair Alopecia Pruritus Skin and musculoskeletal pigmentation changes Weight loss, anorexia Cardiomyopathy (rare) Hemolysis (individuals with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency) Prolongs QT interval Ventricular arrhythmias and torsade de pointes Vertigo Tinnitus Nystagmus Nerve deafness Deafness Irreversible retinopathy with retinal pigmentation changes (bull’s eye appearance) Visual field defects (paracentral scotomas) Visual disturbances (visual acuity) Maculopathies (macular degeneration) Decreased dark adaptation Color vision abnormalities Corneal changes (edema and opacities) Abdominal pain Fatigue Liver function tests abnormal Hepatic failure acute Urticaria Angioedema Bronchospasm Decreased appetite Hypoglycemia Porphyria Weight decreased Sensorimotor disorder Skeletal muscle myopathy or neuromyopathy Headache Dizziness Seizure Ataxia Extrapyramidal disorders such as dystonia Dyskinesia Tremor Rash Pruritus Pigmentation disorders in skin and mucous membranes Hair color changes Alopecia Dermatitis bullous eruptions including erythema multiforme Stevens-Johnson syndrome Toxic epidermal necrolysis Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) Photosensitivity Dermatitis exfoliative Acute generalized exanthematous pustulosis (AGEP); AGEP has to be distinguished from psoriasis; hydroxychloroquine may precipitate attacks of psoriasis Pyrexia Hyperleukocytosis Hypersensitivity to 4-aminoquinoline derivatives Retinal or visual field changes due to 4-aminoquinoline compounds Long-term therapy in children Not effective against chloroquine-resistant strains of P. Individual plans may vary and formulary information changes. Hydroxychloroquine Sulfate - Plaquenil Hydroxychloroquine Uses, Dosage, Side Effects. Hydroxychloroquine sulfate - DrugBank
     
  6. job-pr-it Guest

    Coding Long-term Medications ICD-10 Classifications. The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79.899—Other Long Term Current Drug Therapy.

    ICD-10-CM Diagnosis Code M32.9 Systemic lupus erythematosus.